Apatinib combined with trastuzumab and albumin-bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti-HER2 TKIs: A case report

por Huang, Jiayi, Chen, Xiao, Guo, Jinfeng, Song, Lin, Mu, Yanxi, Zhao, Han, Du, Caiwen
Publicado 2022

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

por Liang, Sixian, Peng, Xun, Li, Xiaoli, Yang, Ping, Xie, Linhao, Li, Yaochen, Du, Caiwen, Zhang, Guojun
Publicado 2014

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

por Liang, Sixian, Peng, Xun, Li, Xiaoli, Yang, Ping, Xie, Linhao, Li, Yaochen, Du, Caiwen, Zhang, Guojun
Publicado 2022

The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases

por Chen, Xuelian, Bai, Xue, Xie, Xiaofeng, Huang, Jiayi, Chen, Liping, Song, Lin, Lan, Xiaofeng, Zhang, Qiuyi, Guo, Jinfeng, Du, Caiwen
Publicado 2023